Spinal Muscular Atrophy: Physical Therapy Management in the New Frontier
Saturday, November 10
2:15 PM - 3:45 PM
Location: Meeting Room 4/5 - Convention Center
1 in 50 people carry the gene for SMA, and in the United States 1 in every 6,000 to 10, 000 people develop spinal muscular atrophy. SMA is a devastating, life threatening illness that until last year had no approved treatment. With the approval of the first treatment by the FDA in December 2016, the face of SMA has changed. With that change has come new standards of care, new treatment philosophies and changed outcomes as these individuals reach milestones previously thought impossible. As physical therapist we are intimately involved with the care of these patients and their families. We are able to intervene and advocate at a level that is imperative to achieve best outcomes and optimize function. With groundbreaking and revolutionary research we can learn to more effectively work together to change the lives of this important group of people.
- Upon attending this presentation, the learner will demonstrate an understanding toward the updates and advancements in medical treatment for patients with SMA.
- Upon attending this presentation, the learner will apply the revised standard of care in case studies for patients with SMA based on type and functional status.
- Upon attending this presentation, the learner will discuss with colleagues the relevant physical therapy updates and clinical recommendations for various settings.
- Upon completion of this course, the learner will demonstrate proficiency in the use of relevant, available resources, immediate application of clinical standard of care and advocacy.